Amplify Weight Loss Drug & Treatment ETF

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell THNR and other ETFs, options, and stocks.

About THNR

THNR tracks a modified market cap-weighted index of companies from developed markets that manufacture and enable GLP-1 agonist pharmaceutical businesses.

Index-Tracked

VettaFi Weight Loss Drug & Treat TR USD

Index-TrackedVettaFi Weight Loss Drug & Treat TR USD

What's in this fund

Sectors

As of January 7, 2026

Healthcare100.00%

Top 10 Holdings (71.15% of total assets)

As of January 7, 2026

NameSymbol% Assets

Novo NordiskNVO13.32%

Eli LillyLLY12.90%

RegeneronREGN6.85%

AmgenAMGN6.78%

Chugai Pharmaceutical Co Ltd4519 (XTKS)6.26%

MerckMRK5.19%

Roche Holding AGROG (XSWX)5.01%

AstraZenecaAZN4.98%

Innovent Biologics Inc01801 (XHKG)4.93%

Shionogi & Co Ltd4507 (XTKS)4.93%

THNR Key Statistics

AUM

3.90M

AUM3.90M

Price-Earnings ratio

23.32

Price-Earnings ratio23.32

30-Day yield

1.45

30-Day yield1.45

Average volume

5.01K

Average volume5.01K

High today

—

High today—

Low today

—

Low today—

Open price

$26.17

Open price$26.17

Volume

0.00

Volume0.00

52 Week high

$26.35

52 Week high$26.35

52 Week low

$18.56

52 Week low$18.56

Expense ratio

0.59

Expense ratio0.59

View Prospectus and Reports

Stock Snapshot

As of today, Amplify Weight Loss Drug & Treatment ETF(THNR) shares are valued at $26.43. The company's market cap stands at 3.92M, with a P/E ratio of 23.32 and a dividend yield of 1.7%.

On 2026-01-12, Amplify Weight Loss Drug & Treatment ETF(THNR) stock opened at $26.17, reached a high of —, and a low of —.

Amplify Weight Loss Drug & Treatment ETF(THNR) shares are trading with a volume of 0, against a daily average of 5.01K.

In the last year, Amplify Weight Loss Drug & Treatment ETF(THNR) shares hit a 52-week high of $26.35 and a 52-week low of $18.56.